Arvinas /ARVN dBET vs iBET

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Topcoin

Rank: Treasurer [?]

Points: 462 [?]

Votes: 6 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Arvinas /ARVN dBET vs iBET

posted on Oct 12, 2018 08:03PM

All

ARVN just IPOed at 500M US on Nasdaq

How do we think Zenith stacks up in Cancer therapeutics vs the ARVN platform ?

They appear earlier stage but just banked 100 Million and already have Pfizer etc onboard

They have prostate program etc..,

The platform targets proteins including Brd4 to degrade rather than be inhibited as in Zenith’s platform technology

Any thoughts on pros and cons ?

Thanks !

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply